Viagra, the anti-impotence drug, was declared safe for sale in the European
Union this week by the European Agency for the Evaluation of Medicinal Products.
Britain’s health secretary, Frank Dobson, says that for the time being the
National ÎçÒ¹¸£Àû1000¼¯ºÏ Service will not pay for it, although Pfizer, the drug’s
manufacturer, says the company has already agreed prices with the NHS. Dobson
promises a definitive ruling in the next few weeks. Other European health
systems are still discussing with Pfizer how much they will pay for the drug.
Viagra will require a prescription across the EU.
More from New Scientist
Explore the latest news, articles and features
Mind
The relationship recession is even bigger for Gen Z than we thought
News
Technology
Killer robots are here – we must finally decide whether to accept them
Leader
Technology
Quantum computer quickly mines cryptocurrency while using less energy
News
Mind
How to sparkle in conversation with strangers
Comment
Popular articles
Trending New Scientist articles
1
Fully autonomous drones have killed human soldiers for the first time
2
Mysterious ‘cold blob’ in the Atlantic suggests the AMOC is weakening
3
The relationship recession is even bigger for Gen Z than we thought
4
First working nuclear clock heralds a new era in timekeeping
5
Toy universe shows that time could be a quantum illusion
6
Why we should all take quantum physics extremely personally
7
Wildlife thrives in solar farm built on restored peatland
8
What’s the secret to living well beyond the average life expectancy?
9
What is a ‘normal’ memory slowdown, and when should I worry?
10
Vaping after quitting smoking is linked to lung cancer
